The similar lipid protein profile between HIVposEVs- and HIVnegEVs-treated apoE−/− mice (with different atherosclerosis burdens) also suggests that cholesterol levels are not a determining factor for the increased atherogenesis associated with HIVposEVs injection in apoE−/− mice. The gene discussed is APOE; the disease is atherosclerosis.